Allianz Asset Management’s Acceleron Pharma XLRN Stock Holding History

Allianz Asset Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-20,995	Closed	-$3.61M	–	2758
2021 Q3	$3.61M	Buy	20,995 +10,455	+99%	+$1.37M	﹤0.01%	1417
2021 Q2	$1.32M	Hold	10,540	–	–	﹤0.01%	1624
2021 Q1	$1.43M	Hold	10,540	–	–	﹤0.01%	1517
2020 Q4	$1.35M	Sell	10,540 -4,345	-29%	-$509K	﹤0.01%	1416
2020 Q3	$1.68M	Sell	14,885 -5,106	-26%	-$508K	﹤0.01%	1309
2020 Q2	$1.91M	Sell	19,991 -4,949	-20%	-$477K	﹤0.01%	1620
2020 Q1	$2.24M	Sell	24,940 -2,669	-10%	-$207K	﹤0.01%	1482
2019 Q4	$1.46M	Buy	+27,609	New	+$1.26M	﹤0.01%	2022

Allianz Asset Management's XLRN Position: Q4 2021 in Review

Allianz Asset Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 20,995 shares — an estimated $3.61M sold.

Allianz Asset Management first reported a position in XLRN in Q4 2019 and held it in 8 quarters. The position peaked at $3.61M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Allianz Asset Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Allianz Asset Management sold 20,995 Acceleron Pharma shares in Q4 2021, an estimated $3.61M.
Allianz Asset Management first reported a position in Acceleron Pharma in Q4 2019 and held it in 8 quarters.
Allianz Asset Management's Acceleron Pharma position peaked at $3.61M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Allianz Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.